← All Greater Cannabis Company, INC filings

Greater Cannabis Company, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OQB
GCAN
Greater Cannabis Company, INC
10-K: Cannabis Co. Faces Going Concern, Delays Clinical Trial
The Greater Cannabis Company reported a significant net loss and cash depletion for 2025, raising substantial doubt about its ability to continue operations while awaiting critical API for its Phase II clinical trial.
OQB
GCAN
Greater Cannabis Company, INC
10-K/A: Greater Cannabis Company Files Amended 10-K, Addressing Auditor Report and Licensing Agreement Details
The Greater Cannabis Company files an amendment to its 2024 annual report to include the 2023 auditor report and additional details on its licensing agreement with Shaare Zedek Scientific Ltd.
OQB
GCAN
Greater Cannabis Company, INC
10-K: Greater Cannabis Company Reports Annual Results for Fiscal Year 2024, Cites Going Concern Uncertainty
The Greater Cannabis Company reports $0 revenue for 2024 and expresses substantial doubt about its ability to continue as a going concern.
OQB
GCAN
Greater Cannabis Company, INC
10-K: Greater Cannabis Company Reports $0 Revenue for 2023, Net Loss of $188,402
The Greater Cannabis Company reported no revenue and a net loss of $188,402 for the year ended December 31, 2023, while highlighting ongoing concerns about its ability to continue as a going concern.